(2019) Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran. International Journal of Drug Policy. pp. 129-134. ISSN 0955-3959

(2018) Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterology & Hepatology. pp. 383-403.

(2017) Estimating the Prevalence of Hepatitis B Virus Infection and Exposure Among General Population in Iran. Hepatitis Monthly. p. 11. ISSN 1735-143X

(2017) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterology & Hepatology. pp. 161-176.

(2016) Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden. Hepatitis Monthly. p. 9. ISSN 1735-143X

(2016) Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepatitis Monthly. p. 14. ISSN 1735-143X

(2015) Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3. Journal of Viral Hepatitis. pp. 4-20. ISSN 1352-0504

(2015) Strategies to manage hepatitis C virus infection disease burden - volume 3. Journal of Viral Hepatitis. pp. 42-65. ISSN 1352-0504

(2015) The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3. Journal of Viral Hepatitis. pp. 21-41. ISSN 1352-0504

(2014) Can we include genetic variants with high linkage disequilibrium into a multiple logistic model? Liver International. p. 964. ISSN 1478-3223

(2014) Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. p. 343. ISSN 0269-2813

(2009) Mass Vaccination Campaign against Hepatitis B in Adolescents in Iran: Estimating Coverage Using Administrative Data. Hepatitis Monthly. pp. 189-195. ISSN 1735-143X

(2009) Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver International. pp. 159-163. ISSN 1478-3223

(2009) Sexual Function: A Comparison Between Male Renal Transplant Recipients and Hemodialysis Patients. Journal of Sexual Medicine. pp. 142-148. ISSN 1743-6095

(2008) Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients. Nephrology. pp. 376-379. ISSN 1320-5358

(2008) Hepatitis B Virus Infection in Iran: A Systematic Review. Hepatitis Monthly. pp. 281-294. ISSN 1735-143X

(2006) Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: A multicenter study. Archives of Iranian Medicine. pp. 319-323. ISSN 10292977 (ISSN)

(2004) Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord. p. 4. ISSN 1472-6823

(2003) Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients. Transplantation Proceedings. pp. 2687-2688. ISSN 0041-1345

(2003) Is preemptive renal transplantation preferred? Transplantation Proceedings. pp. 2598-2601. ISSN 0041-1345

(2003) Patient and graft outcome after living donor renal transplantation in Iran: More than 15-year follow-up. Transplantation Proceedings. pp. 2605-2606. ISSN 0041-1345

(2003) Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. Journal of Gastroenterology and Hepatology. pp. 836-840. ISSN 0815-9319

(2003) Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology. pp. 256-260. ISSN 1320-5358